Oncternal Therapeutics News

Oncternal Therapeutics | EFFECT: Others

May 2 18:10

Oncternal Therapeutics | 424B5: Prospectus

Dec 18, 2021 06:15

Oncternal Therapeutics | 424B5: Prospectus

May 29, 2021 05:23

Oncternal Therapeutics | EFFECT: Others

Apr 16, 2021 12:15

Oncternal Therapeutics | 424B3: Prospectus

Apr 16, 2021 04:31

Oncternal Therapeutics | 424B5: Prospectus

Dec 11, 2020 06:02

Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Dec 10, 2020 19:11

Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Dec 10, 2020 09:15

Oncternal Therapeutics | 424B5: Prospectus

Dec 10, 2020 08:34

Oncternal Therapeutics | 424B5: Prospectus

Nov 19, 2020 09:49

Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 18, 2020 19:05

Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 18, 2020 06:27

Oncternal Therapeutics | 424B5: Prospectus

Nov 18, 2020 06:07

Oncternal Therapeutics | 424B5: Prospectus

Aug 29, 2020 05:24

Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 28, 2020 09:34

Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 28, 2020 05:26

Oncternal Therapeutics | 424B5: Prospectus

Aug 28, 2020 05:24

Oncternal Therapeutics | 424B5: Prospectus

Jul 21, 2020 18:04

Oncternal Therapeutics | 424B5: Prospectus

May 21, 2020 19:51

Oncternal Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 4, 2019 04:27